Christer Karlsson

Title: The Innovative Contributions of Christer Karlsson

Introduction

Christer Karlsson is a notable inventor based in Lindome, Sweden. He has made significant contributions to the field of pharmaceuticals, particularly in drug delivery systems. With a total of 5 patents to his name, Karlsson's work has the potential to impact medical treatments significantly.

Latest Patents

Karlsson's latest patents include a method for the prophylaxis and/or treatment of thromboembolism. This innovative oral IR formulation in solid form utilizes a low molecular weight thrombin inhibitor with pH-dependent dissolution. The formulation is characterized by a filler or a combination of fillers that possess disintegrant properties, comprising more than 35% w/w of the formulation. Another notable patent involves porous hydroxyapatite particles as carriers for drug substances. This drug delivery system is designed for oral administration in solid dry form and incorporates greasy, oily, or sticky substances along with pharmaceutically active ingredients. The system is characterized by a plurality of porous inorganic particles that allow for fast release characteristics.

Career Highlights

Throughout his career, Christer Karlsson has worked with prominent companies in the pharmaceutical industry, including AstraZeneca AB and Astra Aktiebolag. His experience in these organizations has contributed to his expertise in developing innovative drug delivery systems.

Collaborations

Karlsson has collaborated with several professionals in his field, including Per Johan Lundberg and Adam Rosinski. These collaborations have likely enhanced his research and development efforts.

Conclusion

Christer Karlsson's contributions to pharmaceutical innovations demonstrate his commitment to improving medical treatments through advanced drug delivery systems. His patents reflect a deep understanding of the complexities involved in drug formulation and delivery.